Metabolic effects of growth hormone (GH) replacement in children and adolescents with severe isolated GH deficiency due to a GHRH receptor mutation.
AuthorsGleeson, Helena K
Barreto, Elenilde S de A
Oliveira, Carla R P
Pereira, Rossana M C
Clayton, Peter E
Aguiar-Oliveira, Manuel H
AffiliationChristie Hospital, Department of Endocrinology, Manchester, UK. email@example.com
MetadataShow full item record
AbstractBACKGROUND: The interpretation of the true effect of GH replacement therapy (GHRT) on metabolic status in GH deficiency (GHD) is often complicated by differing aetiologies of GHD and by the presence of additional hormone deficits. OBJECTIVE: To study the growth and response of the lipid profile and body composition to GHRT in a cohort of children with the same mutation in the GHRH receptor gene. Design Nine GH-deficient subjects (mean age 12.8 years, range 5-17.5 years; three male) in a rural community in Northeast Brazil were treated with GHRT for 2 years and compared with indigenous normal controls. MAIN OUTCOME MEASURES: Total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), triglycerides (TG) and body composition were measured at baseline and after 3, 12 and 24 months of GHRT. RESULTS: At baseline, the subjects with GHD had an adverse lipid profile, including elevated TC, elevated LDL-C and elevated TG. GHRT normalized TG in 3 months, LDL-C in 12 months and TC in 24 months. At baseline, older pubertal subjects with GHD had adverse body composition, including higher percentage fat mass (%FM), and GHRT induced a reduction in %FM that was maintained after 24 months. By contrast, younger prepubertal subjects did not have an adverse body composition. CONCLUSIONS: Lipid profile was abnormal at baseline, while abnormal body composition was only seen in older subjects in late puberty, indicating that body composition is less sensitive to the effect of GHD than lipid profile. GHRT improves lipid profile at all ages, while it affects body composition only towards the end of growth, emphasizing its importance in achieving normal somatic development in the transition period.
CitationMetabolic effects of growth hormone (GH) replacement in children and adolescents with severe isolated GH deficiency due to a GHRH receptor mutation. 2007, 66 (4):466-74 Clin. Endocrinol.
- Serum leptin and body composition in children with familial GH deficiency (GHD) due to a mutation in the growth hormone-releasing hormone (GHRH) receptor.
- Authors: de A Barretto ES, Gill MS, De Freitas ME, Magalhães MM, Souza AH, Aguiar-Oliveira MH, Clayton PE
- Issue date: 1999 Nov
- Atherogenic lipoprotein phenotype and low-density lipoprotein size and subclasses in patients with growth hormone deficiency before and after short-term replacement therapy.
- Authors: Rizzo M, Trepp R, Berneis K, Christ ER
- Issue date: 2007 Mar
- Serum homocysteine concentrations in children with growth hormone (GH) deficiency before and after 12 months GH replacement.
- Authors: Esposito V, Di Biase S, Lettiero T, Labella D, Simeone R, Salerno M
- Issue date: 2004 Nov
- Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
- Authors: Tanriverdi F, Unluhizarci K, Kula M, Guven M, Bayram F, Kelestimur F
- Issue date: 2005 Jun
- Growth hormone replacement therapy regulates microRNA-29a and targets involved in insulin resistance.
- Authors: Galimov A, Hartung A, Trepp R, Mader A, Flück M, Linke A, Blüher M, Christ E, Krützfeldt J
- Issue date: 2015 Dec